✨ Meet Dr Elin Ryan✨ Elin is a researcher at Oslo University Hospital. Together with Mariana and Tine she is working on cutting-edge therapies as part of #NuCapCure which have the potential to change the lives of millions of people worldwide. Elin is pushing boundaries today, inspiring scientists tomorrow. 💡 On this International Day of Women and Girls in Science, we at #NuCapCure celebrate Mariana, Tine, Elin and all the incredible women pushing boundaries and transforming the world of research! #WomenInScience #STEM #Innovation #FutureOfScience #InternationalDayOfWomenAndGirlsInScience
About us
NuCapCure - Development of innovative proton and neutron therapies with high cancer specificity by 'hijacking' the intracellular chemistry of haem biosynthesis Each year, approximately 240,000 people worldwide are diagnosed with brain cancer. The most lethal type, Glioblastoma multiforme (GBM), also known as “the Terminator”, accounts for 14.6-16% of all primary brain and central nervous system tumours, tragically making it also the most common one. The current standard of care for GBM involves surgery followed by a combination of radiotherapy and chemotherapy. These interventions impose a significant physical and financial burden on patients and healthcare systems, while their curative impact is unfortunately limited. In fact, they only marginally extend patient survival by approximately 15 months, with a survival rate for GBM patients within five years of diagnosis at nearly 6%. This highly unmet medical need presents one of the most substantial challenges for modern oncology and the overall well-being of global societies. The new EU-funded NuCapCure project has been launched to address this challenge and undertake the ambitious mission of redefining the landscape of GBM treatment. The seven partners of the consortium aim to develop two radical, multimodal anticancer treatments highly specific to GBM. Over the next 54 months, NuCapCure will receive a total of €5.9 million in funding from the European Innovation Council's (EIC) Pathfinder programme, which targets visionary and disruptive innovations that can bring about decisive societal change by addressing global challenges.
- Website
-
NuCapCure.eu
External link for NuCapCure
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Brussels
- Founded
- 2024
Updates
-
✨ Meet Tine Therese Raabe ✨ As a technician at Oslo University Hospital, Tine — alongside Mariana — is driving #NuCapCure toward groundbreaking new treatments for #glioblastoma. 🚀 Her dedication is not only shaping the future of science but also inspiring the next generation of women in STEM! #WomenInScience #STEM #Innovation #FutureOfScience #InternationalDayOfWomenAndGirlsInScience
-
-
🌟 Meet Dr Mariana Ferrer Casal 🌟 As a Discovery Project Manager at GalChimia, Mariana is helping drive #NuCapCure’s revolutionary goals forward! 🚀 Her work is shaping the future of scientific discovery, proving that women in STEM are leading the way toward groundbreaking innovation. #WomenInScience #STEM #Innovation #InternationalDayOfWomenAndGirlsInScience #FutureOfScience
-
-
🔬✨ Unpacking STEM Careers: Her Voice in Science ✨🔬 On this International Day of Women and Girls in Science, we celebrate the trailblazers shaping the future! 🚀 As we mark 10 years of this important day, it’s time to pave the way for the women and girls our world needs in STEM. Breaking stereotypes, uplifting role models and fostering inclusive environments — this is how we close the gender gap in science. In our mission to revolutionise treatment for #glioblastoma, one of the deadliest brain tumours with no curative treatment, we are proud of the incredible women leading the charge. 👩🔬 The women driving #NuCapCure today will inspire the next generation of scientists tomorrow. Let’s keep pushing boundaries! 🌍💙 #WomenInScience #STEM #InternationalDayOfWomenAndGirlsInScience #Innovation #GenderEquality
-
🌍🎗️ United by Unique – Turning the Tide on Cancer 🎗️🌍 On World Cancer Day #UnitedByUnique is more than a campaign — it’s a commitment to putting people at the heart of change. Every story, every challenge and every success moves us forward. Project coordinator Theo Theodossiou and our team are working to tackle #Glioblastoma, a rare and deadly brain cancer that in some variations affects even young children and for which there is currently no curative treatment. Together, we're driving a paradigm shift in cancer research in the hope of curing or managing glioblastoma and paving the way for breakthroughs against other cancers once thought incurable. ♥️ When we unite, we change lives. #WorldCancerDay #CancerResearch #Innovation
-
-
As the year comes to an end we reflect on the #successes we have experienced and the #milestones that lay ahead. We are excited for a new year full of possibilities and achievements. The #NuCapCure team together with our partners University of Oslo, GalChimia, Charles University, Centrum výzkumu Řež / Research Centre Řež, EURICE – European Research and Project Office GmbH, National Center for Scientific Research "Demokritos" and UMCG are looking forward to sharing the next phase with you!
-
-
#GlioblastomaAwarenessDay takes place each year in July to recognize the profound impact of #glioblastoma. This day is dedicated to honouring those affected by this devastating disease, raising awareness, and supporting ongoing research efforts. NuCapCure's mission is to revolutionise modern oncology through two ground-breaking treatments for the world's most common yet incurable brain tumour, Glioblastoma multiforme (#GBM), and thus promote the well-being of global societies. "The #NuCapCure project can revolutionise cancer treatment, aiming to offer curative yet cost-effective alternatives for GBM, providing significant benefits for patients, healthcare systems, and the society as a whole", states the coordinator Dr Theo Theodossiou from the Universitetet i Oslo (UiO) | University of Oslo . #GBMDay #eicpathfinder
-
-
NuCapCure reposted this
Our CEO Carme Pampín and CSO Jacobo Cruces are in Bordeaux at the 58th edition of the International Conference on Medicinal Chemistry (RICT 2024). If you are around, do not hesitate to visit us in booth 1! Société de Chimie Thérapeutique SCT #passionforchemistry #CRO #drugdiscovery #organicsynthesis #medicinalchemistry GalChimia acknowledges the support of Xunta de Galicia | IGAPE (Instituto Galego de Promoción Económica) and the European Union (#ERDF) through grant Galicia Exporta Empresas 2024, aimed at promoting international activities by Galician SMEs.
-
-
NuCapCure reposted this
ENGLISH BELOW! 🔬✨ Naše výzkumné centrum je součástí projektu NuCapCure který je zaměřený na revoluci v léčbě agresivního nádoru mozku, glioblastomu multiforme (GBM). 💊🧠Přečtěte si více o našem zapojení a vývoji, průlomových terapií na našem webu, odkaz naleznete v komentářích. 🔬✨Our research centre is part of the NuCapCure project, which aims to revolutionize the treatment of the aggressive brain tumour, glioblastoma multiforme (GBM). 💊🧠 Read more about our involvement and the development therapies in the project on our website! You can find the link in the comments. #NuCapCure #GBM #inovace #innovations
-
-
#NuCapCure introduced at EIC Info Day On April 4th, 2024, the EIC Info Day took place in Vienna, Austria. This event was a collaboration between the European Commission, Austria, the Czech Republic, and Slovakia. It allowed participants to gain insights about opportunities offered by the European Innovation Council (EIC). During the section "From Vision to Reality: EIC Success Stories", our NuCapCure Researchers Milan Jakubek, PhD and Robert Kaplanek from 1. lékařská fakulta UK presented the NuCapCure project. More information about the event can be found here: https://lnkd.in/dBXHazw5
-